Freestyle libre flash glucose monitoring system class ii b professional#
6 In general, use of CGM systems involves a struggle with sensor accuracy during hypoglycaemia and exercise, as shown for both professional (iPro2, Enlite 2, Medtronic, USA) and personal (Minimed 640G, Medtronic Freestyle Libre 1, Abbott, USA Dexcom G4 Platinum, Dexcom, USA) CGM systems. 6 From a physiological point of view, a time lag was observed in the interval needed for glucose to diffuse from the bloodstream into the interstitium. 5Īlthough the flash GM system demonstrated good efficacy in chronic glucose monitoring settings, the accuracy of acute continuous glucose monitoring (CGM) systems was impaired during periods of high rates of change in glucose. 1 The beneficial effects of integrating flash GM technology into diabetes management include: reduced time spent in hypoglycaemia, improved glycaemic variability, 2 lower HbA1c levels 3 and increased numbers of readings per day 4 in individuals with type 1 diabetes. All rights reserved.In July 2018 the US Food and Drug Administration (FDA) approved the Freestyle Libre flash glucose monitoring (flash GM) system (Abbott Diabetes Care Inc, USA) to monitor interstitial glucose concentration without obtaining a capillary blood sample from the fingertip for management of type 1 and type 2 diabetes in individuals 18 years of age and older. HbA1c cardiovascular flash blood glucose monitoring glycaemic control type 1 diabetes.Ĭopyright © 2020 Wolters Kluwer Health, Inc. The technology provides significantly more data than the intermittent results obtained by traditional subcutaneous blood glucose monitoring, which may not capture intervals of extreme variability or nocturnal events. After the 6-month follow-up, two 2/92 users did not wish to continue with the monitoring.įlash glucose monitoring has great potential for the management of type 1 diabetes in the adult population and improving metabolic control/quality of life for people across the world. There was also a narrowing of the distribution of HbA1c, with many fewer people running high HbA1c ≥80 mmol/mol (9.5%). In 92 consecutive users, HbA1c decreased by an average of 10.7 mmol/mol (0.98%) after 3 months, and by 16.1 mmol/mol (1.47%) after 6 months. The mean cohort age was 43 years for men and 39 years for women (overall range 17-83 years). An HbA1c of 60 mmol/mol (7.6%) was taken as the threshold for suboptimal glycaemic control. Initiation was with education and support from one of the diabetes specialist nurses. We report the outcomes of 92 consecutive adults (18 years of age or more) with type 1 diabetes who have begun using the FreeStyle Libre flash glucose monitor in East Cheshire, UK. We describe here how use of the FreeStyle Libre flash monitor has improved the glycaemic control of many people with type 1 diabetes where the new technology has been intensively deployed. Many people with type 1 diabetes continue to run high HbA1c levels with associated elevated risk of cardiovascular events and increased mortality.
0 kommentar(er)
